Pharmaceutical Launch Strategy: Pipeline to Market

Simulation where participants act as Commercial Launch Director for CARDIVEX (empavatin), allocating an $18M budget across six strategic levers over five rounds to take a novel Type 2 Diabetes drug from regulatory approval to commercial profitability against branded competitors and impending generic entry.